Cargando…
PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429189/ http://dx.doi.org/10.1097/01.HS9.0000851468.21705.43 |
_version_ | 1784779360713048064 |
---|---|
author | Diakonov, D. Perfilova, E. Minaev, M. |
author_facet | Diakonov, D. Perfilova, E. Minaev, M. |
author_sort | Diakonov, D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94291892022-08-31 PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA Diakonov, D. Perfilova, E. Minaev, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429189/ http://dx.doi.org/10.1097/01.HS9.0000851468.21705.43 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Diakonov, D. Perfilova, E. Minaev, M. PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title | PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title_full | PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title_fullStr | PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title_full_unstemmed | PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title_short | PB2160: ASSOCIATION OF BCL-2 EXPRESSING TUMOR CELLS WITH RESPONSE TO FRONTLINE CHEMOTHERAPY IN NODULAR SCLEROSIS HODGKIN LYMPHOMA |
title_sort | pb2160: association of bcl-2 expressing tumor cells with response to frontline chemotherapy in nodular sclerosis hodgkin lymphoma |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429189/ http://dx.doi.org/10.1097/01.HS9.0000851468.21705.43 |
work_keys_str_mv | AT diakonovd pb2160associationofbcl2expressingtumorcellswithresponsetofrontlinechemotherapyinnodularsclerosishodgkinlymphoma AT perfilovae pb2160associationofbcl2expressingtumorcellswithresponsetofrontlinechemotherapyinnodularsclerosishodgkinlymphoma AT minaevm pb2160associationofbcl2expressingtumorcellswithresponsetofrontlinechemotherapyinnodularsclerosishodgkinlymphoma |